DAX24.423 +1,3%Est505.646 +1,2%MSCI World4.329 +0,2%Top 10 Crypto16,90 +3,7%Nas22.850 +0,4%Bitcoin103.240 +2,3%Euro1,1721 -0,1%Öl64,19 -1,9%Gold3.856 -0,3%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
DroneShield A2DMAA Rheinmetall 703000 NVIDIA 918422 RENK RENK73 Siemens Energy ENER6Y Tesla A1CX3T Novo Nordisk A3EU6F Plug Power A1JA81 Bayer BAY001 Alibaba A117ME HENSOLDT HAG000 Lufthansa 823212 BASF BASF11 Deutsche Telekom 555750 thyssenkrupp 750000
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX letztlich kräftig im Plus -- US-Börsen fester -- Tesla meldet Rekord-Auslieferungen -- BioNTech, DroneShield, Siemens Energy, Novo Nordisk, BYD, Rüstungsaktien, Wolfspeed, Stellantis im Fokus
Top News
Tesla-Aktie im Fokus: Hacker deckt auf - So abgespeckt wird Teslas neuer Model Y Tesla-Aktie im Fokus: Hacker deckt auf - So abgespeckt wird Teslas neuer Model Y
Warum der Euro zum Dollar fällt Warum der Euro zum Dollar fällt
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Anixa Biosciences Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
2,74 EUR -0,06 EUR -2,14 %
STU
3,29 USD -0,10 USD -2,95 %
BTT
Anixa Biosciences jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.92,51 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2N6ZF

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS03528H1095

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolANIX

Anixa Biosciences Aktien News

DatumMeistgelesen
PR NewswireAnixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports"
PR NewswireAnixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer
PR NewswireAnixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview
PR NewswireAnixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum
PR NewswireAnixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention
PR NewswireAnixa Biosciences CEO Provides Letter to Shareholders
finanzen.netAnixa Biosciences stellte Ergebnisse des abgelaufenen Quartals vor
PR NewswireAnixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10
PR NewswireAnixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
PR NewswireAnixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
PR NewswireAnixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
PR NewswireAnixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024
PR NewswireAnixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
PR NewswireAnixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development
PR NewswireAnixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial
PR NewswireAnixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine
finanzen.netAnixa Biosciences hat Bilanz für das abgelaufene Quartal gezogen
PR NewswireAnixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium
PR NewswireAnixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
PR NewswireAnixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting
PR NewswireAnixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
PR NewswireAnixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology
PR NewswireAnixa Biosciences Announces $5 Million Share Repurchase Program
PR NewswireAnixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial
finanzen.netAnixa Biosciences stellte Zahlen zum jüngsten Quartal vor
PR NewswireAnixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
PR NewswireAnixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja
PR NewswireAnixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024
PR NewswireAnixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
PR NewswireAnixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
PR NewswireAnixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
PR NewswireAnixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference
PR NewswireAnixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology
PR NewswireAnixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024
PR NewswireAnixa Biosciences to Present at Biotech Showcase 2024

Anixa Biosciences News

Anixa Biosciences News: auf dieser Seite finden Sie alle Anixa Biosciences News und Nachrichten zur Anixa Biosciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Anixa Biosciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Anixa Biosciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.